LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 265 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 2.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $409,000 | -73.0% | 3,918 | -46.2% | 0.01% | -62.1% |
Q2 2018 | $1,514,000 | -3.3% | 7,281 | -23.2% | 0.03% | -12.1% |
Q1 2018 | $1,565,000 | -25.0% | 9,478 | -37.6% | 0.03% | -26.7% |
Q4 2017 | $2,086,000 | +37.6% | 15,178 | +34.9% | 0.04% | +55.2% |
Q3 2017 | $1,516,000 | -11.6% | 11,252 | -20.3% | 0.03% | -14.7% |
Q2 2017 | $1,714,000 | -55.9% | 14,115 | -61.1% | 0.03% | -69.4% |
Q1 2016 | $3,890,000 | +29.6% | 36,329 | +29.9% | 0.11% | +56.3% |
Q4 2015 | $3,001,000 | -12.6% | 27,975 | -37.2% | 0.07% | -18.4% |
Q1 2015 | $3,435,000 | -71.6% | 44,553 | -80.4% | 0.09% | -67.3% |
Q4 2014 | $12,076,000 | +15.2% | 226,994 | +1.3% | 0.27% | +11.3% |
Q3 2014 | $10,483,000 | +18.5% | 224,181 | +56.5% | 0.24% | -16.7% |
Q2 2014 | $8,849,000 | -7.4% | 143,233 | +0.9% | 0.29% | +3.2% |
Q1 2014 | $9,551,000 | +51.0% | 142,000 | +18.1% | 0.28% | +74.8% |
Q4 2013 | $6,326,000 | +89.1% | 120,274 | +34.5% | 0.16% | +74.7% |
Q2 2013 | $3,345,000 | – | 89,400 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |